Oncology: Immunotherapy
Immunotherapy
Classification
- Checkpoint Inhibitors
- Monoclonal Antibodies
- Cytokines
- Adoptive Cell Therapy
- Cancer Vaccines
Checkpoint Inhibitors
- Ipilimumab (Yervoy)
- Mechanism: CTLA-4 Inhibitor (Stimulates at Immune Checkpoint)
- Use: Melanoma & RCC
- Pembrolizumab (Keytruda)
- Mechanism: PD-1 Inhibitor
- Use: Melanoma, NSCLC, H&N SCC
- Nivolumab (Opdivo)
- Mechanism: PD-1 Inhibitor
- Use: Melanoma, NSCLC, RCC
- Atezolizumab (Tecentriq)
- Mechanism: PD-L1 Inhibitor
- Use: Lung Cancers, Liver Cancers & Breast Cancers
- Avelumab (Bavencio)
- Mechanism: PD-L1 Inhibitor
- Use: Merkel Cell Carcinoma & Urothelial Cancers
- Durvalumab (Imfinzi)
- Mechanism: PD-L1 Inhibitor
- Use: NSCLC
Monoclonal Antibodies (MAB)
- Bevacizumab (Avastin)
- Mechanism: Anti-VEGF
- Use: Metastatic Colorectal CA
- Can Affect the Liver & Should Limit Dose Prior to Metastasectomy
- Can Increase Risk of Leak
- Cetuximab (Erbitux)
- Mechanism: Binds EGFR
- Use: Metastatic Colorectal CA (K-RAS Wild Type) & H&N Cancers
- Trastuzumab (Herceptin)
- Mechanism: Binds HER2
- Use: Breast & Stomach Cancer
- Rituximab (Mabthera)
- Mechanism: Binds CD-20
- Use: CLL & Non-Hodgkin Lymphoma
Cytokines
- Aldesleukin (IL-2/Proleukin)
- Use: RCC
- Interferon (Intron A)
- Rarely Used in Modern Practice
- Use: RCC & Leukemia
Adoptive Cell Therapy (Cellular Immunotherapy)
- Tumor-Infiltrating Lymphocyte (TIL) Therapy – Harvests Naturally Occurring T Cells Within the Tumor, Actives/Expands & Then Reinfuses Them
- Engineered T Cell Receptor (TCR) Therapy – Harvests Patient T Cells & Adds New T Cell Receptors to Target Specific Cancer Antigens
- Chimeric Antigen Receptor (CAR) T Cell Therapy – Equips T Cells with Synthetic Receptors
- Natural Killer (NK) Cell Therapy
Cancer Vaccines
- Prophylactic Vaccines:
- Human Papillomavirus (HPV) Vaccine
- Prevents Cervical Cancer & Some Anal/Throat Cancers
- Hepatitis B Virus (HBV) Vaccine
- Prevents HBV & Associated HCC
- Human Papillomavirus (HPV) Vaccine
- Therapeutic Vaccines:
- Bacillus Calmette-Guerin (BCG) Vaccine
- Originally Developed for TB
- Now Used for Bladder Cancer Treatment
- Sipuleucel-T
- Treats Advanced Prostate Cancer
- Talimogene Laherparepvec
- Treats Melanoma
- Bacillus Calmette-Guerin (BCG) Vaccine